Bryan Hughes
Managing Director
Bryan Hughes is a Managing Director of PMCF and leads the firm’s Healthcare team. In addition to leading this team, he also assists the firms’ transactional needs within the business services & technology and consumer, food, & retail sectors. He has more than 20 years of industry experience advising clients with mergers and acquisitions, leveraged buyouts, private placements, financings, valuation, and strategic consulting. From large global companies to small, privately-held businesses, Bryan’s clients include contract manufacturers, life sciences companies, diagnostics businesses, drug delivery services, laboratories, and medical device manufacturers. He has completed over 30 transactions with a combined deal value totaling more than $5 billion.
Bryan began his career at PMCF as an Analyst. Over his tenure at the firm, he was promoted several times, advancing to his current role as Managing Director. Bryan has written numerous articles for healthcare and medical technology industry publications. He is a frequent speaker at business, media, and industry organization events, sharing his insight of various investment banking topics, such as M&A and macro trends within the medical manufacturing and healthcare industries.
Bryan earned a BBA with an emphasis in finance from the Stephen M. Ross School of Business at the University of Michigan. He is a licensed securities representative holding his Series 7 and 63 registrations.
Transaction Experience
PMCF Advises CLM Enterprises, Inc. on its Sale to an Employee Stock Ownership Plan
PMCF Advises Raland Compliance Partners in its Sale to Akkodis, A Global Digital Engineering Company and Part of The Adecco Group
PMCF Advises The Partner Companies, LLC in its Acquisition of UPG Company, LLC
PMCF Advises Eagle Pharmacy in its Sale to J. Knipper and Company
PMCF Advises Rhythmlink International, LLC In Its Sale Transaction To New Heritage Capital
PMCF advises Wright & Filippis in the sale of its Specialty Seating and Mobility division to National Seating & Mobility
PMCF advises Respiratory Technologies, Inc. in its sale transaction to Royal Philips
PMCF advises Mountainside Medical in its sale transaction to Tecomet Inc.
Publications
2026 Medtech M&A Outlook Strengthens as Buyers Prioritize Innovation and Resilience
Medtech is entering 2026 with a healthier M&A environment supported by improved financing conditions, resilient sector performance, and a more straightforward path for strategic buyers and private equity.
Medical Technology M&A Pulse – Q3 2025
M&A activity in the Medical Technology sector remained subdued in Q3 2025 at 102 announced transactions, significantly below the 165 deals recorded in Q3 2024.
Tariffs & Workforce Talent: Two Factors Shaping Healthcare M&A in 2025
Tariffs and staffing stability remain key factors shaping healthcare and MedTech M&A in 2025.
Medical Technology M&A Pulse – Q2 2025
M&A activity in the Medical Technology sector remained subdued in Q2 2025, with 104 announced transactions, a decline from the 128 deals recorded in Q2 2024.
How AI Continues To Drive MedTech M&A
Capital continues to flow into MedTech M&A as companies pursue AI-driven solutions to streamline administrative tasks and drive improved patient outcomes.
